
Facebook received some lukewarm news on Wall Street courtesy of analyst Jason Helfstein of Oppenheimer & Co., who reiterated an “outperform” rating on the social network’s stock and lowered his target price to $32 per share from $33.

Facebook received some lukewarm news on Wall Street courtesy of analyst Jason Helfstein of Oppenheimer & Co., who reiterated an “outperform” rating on the social network’s stock and lowered his target price to $32 per share from $33.
We're kicking off our upcoming Social Media Marketing Boot Camp with a special keynote presentation by Ella Chick (left), the digital producer at Anderson Cooper 360°. She'll discuss how the network uses social media for breaking news and leverages social media to draw attention to organizations and causes. Learn more about our program and register here. 
Facebook’s initial public offering may not have lived up to expectations on the Nasdaq exchange, with the stock slumping from its $38-per-share debut May 18 to approximately $32.25 at the time of this post, but that hasn’t stopped at least 160 U.S.-based mutual funds and exchange-traded funds from adding the social network to their mix.

A total of 38.5 percent of the 421,233,615 Facebook shares purchased by underwriters prior to its initial public offering went to Morgan Stanley, while E*Trade, which had been touted as the best source of stock in the social network for individual investors, received only 0.05 percent of the shares, according to an amendment to Facebook’s S-1 filing with the Securities and Exchange Commission, filed after the close of trading Friday.